The user facility reported to terumo cardiovascular that prior to cardiopulmonary bypass, during setup, a broken manifold was found on the oxygenator. *no patient involvement, *product was changed out, *procedure was completed successfully.
|
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on september 6, 2018.(b)(4).The actual sample was not returned for evaluation; however, a photo was provided and shows the manifold in a different state of integrity as shipped.This confirms the damage to the sampling manifold.A retention sample from the same product code and lot number combination was visually inspected and no damage was observed.All reservoirs are 100% visually inspected at several points in the production process.The packaging of the product also ensures protection against damage to the sampling manifold.It is likely that the unit was damaged by a shock force at some point during the handling of the product; however, when or how this shock force was applied was not able to be determined.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|